INNT - Innovate Biopharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener
14 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-11-30 | INNT | Proujansky Roy | Dir | P - Purchase | $2.63 | +1,400 | 1,400 | New | +$3,682 | ||||||
2018-11-30 | INNT | Laumas Sandeep | Exec COB | P - Purchase | $2.63 | +3,000 | 766,373 | 0% | +$7,890 | ||||||
2018-11-29 | INNT | Prior Christopher P. | CEO | P - Purchase | $2.75 | +5,000 | 7,009 | +249% | +$13,750 | ||||||
2018-11-29 | INNT | Laumas Sandeep | Exec COB | P - Purchase | $2.56 | +3,000 | 763,373 | 0% | +$7,670 | ||||||
2018-09-14 | INNT | Prior Christopher P. | CEO | P - Purchase | $5.82 | +200 | 2,009 | +11% | +$1,164 | ||||||
2018-09-12 | INNT | Prior Christopher P. | CEO | P - Purchase | $6.13 | +500 | 1,809 | +38% | +$3,065 | ||||||
2018-09-07 | INNT | Laumas Sandeep | Exec COB | P - Purchase | $6.10 | +500 | 760,373 | 0% | +$3,050 | ||||||
2018-08-30 | INNT | Laumas Sandeep | Exec COB | P - Purchase | $5.24 | +500 | 759,123 | 0% | +$2,620 | ||||||
2018-08-30 | INNT | Prior Christopher P. | CEO | P - Purchase | $5.20 | +309 | 1,309 | +31% | +$1,607 | ||||||
| A | 2018-08-28 | INNT | Laumas Sandeep | Exec COB | P - Purchase | $4.90 | +250 | 758,623 | 0% | +$1,225 | |||||
2018-08-28 | INNT | Prior Christopher P. | CEO | P - Purchase | $4.93 | +1,000 | 1,000 | New | +$4,930 | ||||||
2018-08-28 | INNT | Laumas Sandeep | Exec COB | P - Purchase | $5.01 | +750 | 1,000 | +300% | +$3,759 | ||||||
| M | 2018-08-24 | INNT | Almenoff June Sherie | COO, Chief Medical Officer | P - Purchase | $4.92 | +1,400 | 1,400 | New | +$6,885 | |||||
| M | 2016-07-13 | INNT | Clarke David H | Former CEO, Dir | P - Purchase | $0.59 | +923,573 | 3,136,900 | +42% | +$542,272 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |